Paysign to Attend Asembia Specialty Pharmacy Summit, April 28-May 02, 2024 Paysign will be attending the 2024 Asembia Specialty Pharmacy Summit, taking place April 28-May 02, in Las Vegas. The Patient Affordability team will be hosting cocktail style gatherings, as well as one-on-one meetings with interested clients throughout the week. To get in touch or… Read more »
HENDERSON, Nev. – March 26, 2024 – (ACCESSWIRE) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today, announced financial results for the fourth quarter and full-year 2023. “We are exceptionally pleased with our financial performance in 2023, as it marked… Read more »
Paysign is a Sponsor at the 2024 Pharmaceutical Compliance Congress Conference in McLean, VA. Paysign will be a sponsor at the upcoming Pharmaceutical Compliance Congress Conference in McLean, VA, April 16-18, 2024. This three day conference will consist of hundreds of professionals that will take part in compelling discussions on the most pressing topics affecting… Read more »
ATHENS, Greece – March 14, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their sponsorship and attendance of the International Plasma Protein Congress to be held April 16-17, 2024, in Athens, Greece. Paysign has… Read more »
Sandy Ortins Joins as VP, EFT Services HENDERSON, Nev. – March 13, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today announced a key executive recruitment that supports their foundation as an end-to-end payment processor. Sandy… Read more »
BOSTON – March 12, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference to be held March 26-29, 2024, in Boston, Massachusetts…. Read more »
PHILADELPHIA – March 11, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their sponsorship of the 2024 ACCESS USA Conference to be held March 19-21, 2024, in Philadelphia, PA. Paysign has been a long-time… Read more »
Our guest post, “Copay Comes Full Circle – An Industry Ready for Disruption” is featured on Drug Channels, an established site which includes expert insights on pharmaceutical economics and the drug distribution system. This article discusses how copay programs have become commoditized – and identifies how many other patient affordability providers have poured resources into… Read more »
Paysign is eager to be an exhibition partner at the 7th Annual Gene Therapy for Rare Disorders Summit in Boston, MA on March 26-29, 2024. This annual event returns as the industry’s leading meeting for success stories, as well as tackling key challenges that face clinical therapies today. Our Patient Affordability team will be there… Read more »
Henderson, Nev. – February 27, 2024 – (Business Wire) – Paysign Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss fourth quarter and full-year 2023 earnings at 5:00 p.m. EDT on Tuesday, March 26, 2024. Participant details are as follows: U.S…. Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.